Wendy Kohlmann

9.7k total citations · 1 hit paper
111 papers, 3.0k citations indexed

About

Wendy Kohlmann is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Wendy Kohlmann has authored 111 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Genetics, 38 papers in Oncology and 29 papers in Pathology and Forensic Medicine. Recurrent topics in Wendy Kohlmann's work include BRCA gene mutations in cancer (51 papers), Genetic factors in colorectal cancer (28 papers) and Cancer Genomics and Diagnostics (20 papers). Wendy Kohlmann is often cited by papers focused on BRCA gene mutations in cancer (51 papers), Genetic factors in colorectal cancer (28 papers) and Cancer Genomics and Diagnostics (20 papers). Wendy Kohlmann collaborates with scholars based in United States, Canada and Australia. Wendy Kohlmann's co-authors include Joshua D. Schiffman, Harriet Druker, Amanda Gammon, Lisa G. Aspinwall, Sapna Syngal, Sancy A. Leachman, Randall W. Burt, Anita Villani, Jonathan D. Wasserman and Stephen B. Gruber and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wendy Kohlmann

105 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

2024 67 citations Wendy Kohlmann et al. profile →

Peers

Countries citing papers authored by Wendy Kohlmann

Since Specialization

Citations

This map shows the geographic impact of Wendy Kohlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Kohlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Kohlmann more than expected).

Fields of papers citing papers by Wendy Kohlmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Kohlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Kohlmann. The network helps show where Wendy Kohlmann may publish in the future.

Co-authorship network of co-authors of Wendy Kohlmann

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Kohlmann. A scholar is included among the top collaborators of Wendy Kohlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Kohlmann. Wendy Kohlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pancreatic Cancer Risk and Screening Outcomes in Li-Fraumeni Syndrome 2025 ·Pancreas ·(unknown), (unknown), (unknown), (unknown), Anh N. Le, (unknown), (unknown), (unknown), Kristin Zelley, Luke Maese, Suzanne P. MacFarland, Wendy Kohlmann, (unknown), Bryson W. Katona	1
2	Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibility 2025 ·BMC Cancer ·(unknown), Melody S. Goodman, (unknown), Guilherme Del Fiol, Rachel Hess, David W. Wetter, Daniel Chavez‐Yenter, (unknown), (unknown), (unknown), Richard L. Bradshaw, Wendy Kohlmann, Sarah V. Colonna, (unknown), (unknown), Saundra S. Buys, Ophira Ginsburg, Kensaku Kawamoto, Kimberly A. Kaphingst	1
3	Women’s preferences for genetic screening in routine care: A qualitative study 2024 ·Patient Education and Counseling ·Anne C. Madeo, Wendy Kohlmann, (unknown), (unknown), Erin Rothwell, Kimberly A. Kaphingst	0
4	Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith–Wiedemann Syndrome and Other Predisposition Syndromes 2024 ·Clinical Cancer Research ·Jennifer M. Kalish, (unknown), Gaëlle Bougeard, Garrett M. Brodeur, Lisa Diller, Andréa S. Doria, Jordan R. Hansford, Steven D. Klein, Wendy Kohlmann, Christian P. Kratz, Suzanne P. MacFarland, Kristian W. Pajtler, Surya P. Rednam, Jaclyn Schienda, Lisa J. States, Anita Villani, Rosanna Weksberg, Kristin Zelley, Gail E. Tomlinson, Jack Brzezinski	9
5	Update on Surveillance Guidelines in Emerging Wilms Tumor Predisposition Syndromes 2024 ·Clinical Cancer Research ·Jack Brzezinski, (unknown), Gaëlle Bougeard, Garrett M. Brodeur, Lisa Diller, Andréa S. Doria, Jordan R. Hansford, Wendy Kohlmann, Christian P. Kratz, Suzanne P. MacFarland, Kristian W. Pajtler, Surya P. Rednam, Jaclyn Schienda, Lisa J. States, Anita Villani, Rosanna Weksberg, Kristin Zelley, Gail E. Tomlinson, Jennifer M. Kalish	2
6	Management of bilateral head and neck paragangliomas at a single‐institution across four decades 2024 ·Head & Neck ·(unknown), (unknown), Anne Naumer, Luke Buchmann, Wendy Kohlmann, Hilary C. McCrary, Neil S. Patel, Mana Espahbodi	3
7	CHEK2 Founder Variants and Thyroid Cancer Risk 2024 ·Thyroid ·Pamela Brock, (unknown), Taina T. Nieminen, Carlos H.F. Chan, Wendy Kohlmann, (unknown), Song Yao, (unknown), (unknown), Jill Kolesar, Bodour Salhia, Pat Gulhati, J. Kevin Hicks, Matthew D. Ringel	4
8	Enhanced family history-based algorithms increase the identification of individuals meeting criteria for genetic testing of hereditary cancer syndromes but would not reduce disparities on their own 2023 ·Journal of Biomedical Informatics ·Richard L. Bradshaw, Kensaku Kawamoto, (unknown), Melody S. Goodman, Wendy Kohlmann, Daniel Chavez‐Yenter, (unknown), (unknown), Kimberly A. Kaphingst, Guilherme Del Fiol	3
9	Experiences of patients and family members with follow-up care, information needs and provider support after identification of Lynch Syndrome 2023 ·Hereditary Cancer in Clinical Practice ·Ryan Mooney, Yelena P. Wu, (unknown), (unknown), Wendy Kohlmann, (unknown), Kimberly A. Kaphingst	2
10	Discrepancies between tumor genomic profiling and germline genetic testing 2022 ·ESMO Open ·(unknown), (unknown), Samantha Greenberg, Wendy Kohlmann, Joanne Jeter, Sarah V. Colonna, Theresa L. Werner, Conan G. Kinsey, Glynn Weldon Gilcrease, John R. Weis, Jonathan Whisenant, Vaia Florou, Ignacio Garrido‐Laguna	10
11	Germline predisposition to soft tissue sarcoma 2022 ·Journal of Cancer Metastasis and Treatment ·(unknown), (unknown), Joshua D. Schiffman, Wendy Kohlmann, Luke Maese	5
12	Lung Cancer in Li-Fraumeni Syndrome 2021 ·JCO Precision Oncology ·(unknown), (unknown), (unknown), Wendy Kohlmann, Anne Naumer, (unknown), (unknown), Joshua D. Schiffman, Luke Maese	6
13	Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma–pheochromocytoma syndrome 2020 ·Genetics in Medicine ·Samantha Greenberg, Michelle F. Jacobs, Heather Wachtel, (unknown), (unknown), Debbie L. Cohen, (unknown), (unknown), Anne Naumer, Amanda M. Schaefer, Wendy Kohlmann, Katherine L. Nathanson, Tobias Else, Lauren Fishbein	18
14	A pilot study of a telehealth family‐focused melanoma preventive intervention for children with a family history of melanoma 2019 ·Psycho-Oncology ·Yelena P. Wu, Kenneth M. Boucher, Nan Hu, Jennifer L. Hay, Wendy Kohlmann, Lisa G. Aspinwall, Deborah J. Bowen, (unknown), (unknown), Douglas Grossman, Kathi Mooney, Sancy A. Leachman, Kenneth P. Tercyak	4
15	Population-based relative risks for specific family history constellations of breast cancer 2019 ·Cancer Causes & Control ·Frederick S. Albright, Wendy Kohlmann, Leigh Neumayer, Saundra S. Buys, Cindy Matsen, Kimberly A. Kaphingst, Lisa Cannon‐Albright	11
16	Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood 2017 ·Clinical Cancer Research ·Surya P. Rednam, Ayelet Erez, Harriet Druker, Katherine A. Janeway, Junne Kamihara, Wendy Kohlmann, Katherine L. Nathanson, Lisa J. States, Gail E. Tomlinson, Anita Villani, Stephan D. Voss, Joshua D. Schiffman, Jonathan D. Wasserman	174
17	Breast Cancer Risk Reduction Decisions of the BRCA -Positive Patient: An Observational Study at a Single Institution 2016 ·Journal of Women s Health ·(unknown), (unknown), Layla A. Anderson, Jian Ying, Wendy Kohlmann	11
18	Impact of melanoma genetic test reporting on perceived control over melanoma prevention 2015 ·Journal of Behavioral Medicine ·Lisa G. Aspinwall, Tammy K. Stump, Jennifer M. Taber, Wendy Kohlmann, Samantha L. Leaf, Sancy A. Leachman	10
19	Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families 2013 ·Familial Cancer ·Kory Jasperson, Wendy Kohlmann, Amanda Gammon, (unknown), Luke Buchmann, Jason P. Hunt, Anne C. Kirchhoff, H. Jack Baskin, Akram M. Shaaban, Joshua D. Schiffman	70
20	Hamartomatous polyposis syndromes 2009 ·Best Practice & Research Clinical Gastroenterology ·Amanda Gammon, Kory Jasperson, Wendy Kohlmann, Randall W. Burt	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact